NOV 18, 2017 2:29 PM PST

Targeting Prostate Specific Membrane Antigens in Renal Cell Carcinoma

WRITTEN BY: Courtney Schaal

Prostate Specific Membrane antigens (PSMA) encoded by the gene FOLH1, and also known as glutamate carboxypeptidase 2, are transmembrane proteins that have had great utility in the molecular imaging of prostate cancer using positron emission tomography (PET) and detecting its presence, as well as being targeted by small molecules with radionuclides, and exploited therapeutically.  PSMA is expressed normally in non-malignant prostate epithelial cells, but is well known to be upregulated in prostate tumors.  Aside from being expressed in cells of the prostate, PSMA is expressed by endothelial cells including those of the vasculature networks of other solid tumors such as renal cell carcinoma (RCC).

RCC is the most common type of kidney cancer occurring in adults, accounting for nearly 95% of all cases.  Patients presenting with localized RCC typically undergo partial or in some cases complete removal of the effected kidney, and have a survival rate of 65-90%.  This number decreases dramatically if the disease has advanced and metastasized to other organs.  As with many cancers, typically by the time a RCC patient presents in the clinic they have advanced disease.  This is largely because RCC tends to be asymptomatic until later stages of progression, so determining markers for early detection would be valuable and potentially life-saving.  Two scientists at the James Buchanan Brady Urological Institute and Department of Urology at Johns Hopkins University in Baltimore, Maryland have utilized the fact that PSMA is expressed in the neovasculature of RCC, and used PSMA-targeted PET radio labels to successfully image RCC in their patients, and with greater sensitivity than traditional imaging modalities allowing them to detect metastatic disease in clear cell RCC (ccRCC).  Further, Sophia Spatz, a researcher at the Clinic of Urology, University Hospital Bonn in Bonn, Germany, and her colleagues published findings that PSMA was not only expressed in a cohort of 257 RCC patient tumors by histological staining, but the levels of expression correlated with disease stage and grade, as well as overall survival.  These findings were further confirmed by RNA expression data from The Cancer Genome Atlas.

These reports lend evidence that PSMA may also have utility in diagnostic imaging and therapeutic targeting in RCC in addition to its more traditional use in prostate cancer.  If it could be effectively targeted in RCC, this holds potential to offer a therapeutic intervention even for advanced disease for which there are currently no good treatment options, and to date remains incurable.    

Sources: Nature Reviews Urology, Wikipedia, Journal of Urology, Pixabay, Youtube/Health Tips

 

 

 

 

About the Author
You May Also Like
JUN 09, 2020
Drug Discovery & Development
Psychedelic DMT Improves Wellbeing in 89% of People
JUN 09, 2020
Psychedelic DMT Improves Wellbeing in 89% of People
DMT is a powerful psychedelic drug known to produce visions involving 'other beings' like elves, aliens, and dei ...
JUN 24, 2020
Drug Discovery & Development
Gilead to Test Inhalable Remdesivir Against COVID-19
JUN 24, 2020
Gilead to Test Inhalable Remdesivir Against COVID-19
Gilead has announced that it will soon start trials for an inhalable form of Remdesivir, the first drug to receive Emerg ...
JUL 01, 2020
Cancer
The MicroRNA That Can Regulate Tumor Vascularization in Liver Cancer
JUL 01, 2020
The MicroRNA That Can Regulate Tumor Vascularization in Liver Cancer
Angiogenesis is the vascularization, or generation of blood vessels, of a part of the body. It is a normal function of h ...
JUL 02, 2020
Drug Discovery & Development
Common Asthma Drug Could Treat Alzheimer's
JUL 02, 2020
Common Asthma Drug Could Treat Alzheimer's
Researchers from Lancaster University, England, have found that Salbutamol, a medication commonly used to treat asthma, ...
JUL 07, 2020
Drug Discovery & Development
Software That Finds Drug-Resistant Bacteria
JUL 07, 2020
Software That Finds Drug-Resistant Bacteria
Finding drug-resistant genes in bacteria remains a challenge. However, scientists at Washington State University have de ...
JUL 21, 2020
Drug Discovery & Development
New Drug Discoveries are Due To Good Labs
JUL 21, 2020
New Drug Discoveries are Due To Good Labs
A study suggests that the quality of lab procedures performed heavily influences the rate of drug discoveries. These fin ...
Loading Comments...